GlobeNewsWire · TIL · October 26, 2026

Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026

Get the app for more

Explore stock news, insights and company research.